A Single Dose of Psilocybin Mushrooms Can Reduce Anxiety for Nearly Five Years

von pgd | Jan 22, 2020 | Forschung

A 2016 study found that a single dose of shrooms can significantly reduce cancer patients‘ fear of death, and a new follow-up study has found that these benefits can last for years. Nearly five years ago, a team of researchers conducted a landmark trial...

New research confirms lingering mood benefit of psychedelics – Neuroscience News

von pgd | Jan 22, 2020 | Forschung

Summary: Psychedelics, such as psilocybin, provide lasting improvements in mood and feelings of social connectedness after the effect of the drug has worn off. Source: Yale People who had recently used psychedelics such as psilocybin report a sustained improvement in...

The ethics of psychedelic research in disorders of consciousness

von pgd | Nov 30, 2019 | Forschung

Abstract This article provides an ethical analysis of psychedelic research involving disorders of consciousness patients. We apply two internationally accepted approaches for analyzing the ethics of human research, the Value-Validity Framework and Component Analysis,...

Toward a contextual psychedelic-assisted therapy: Perspectives from Acceptance and Commitment Therapy and contextual behavioral science – ScienceDirect

von pgd | Nov 30, 2019 | Forschung

Toward a contextual psychedelic-assisted therapy: Perspectives from Acceptance and Commitment Therapy and contextual behavioral science Abstract After two decades of quiescence, clinical psychedelic research re-started in the 1990s and is rapidly accelerating. Early...

The ultimate Psychedelics research review

von pgd | Nov 30, 2019 | Forschung

A comprehensive review of research literature on Psychedelics, for the lay person (2019) In this post you are going to learn everything researchers have discovered to date, on both Psychedelics as well as Non-psychedelic hallucinogens. We’ll share findings in research...

MDMA makes people cooperative, but not gullible

von pgd | Nov 21, 2018 | Forschung

New research from King’s College London has found that MDMA, the main ingredient in ecstasy, causes people to cooperate better—but only with trustworthy people. In the first study to look in detail at how MDMA impacts cooperative behaviour the researchers also...